Inflammation & Immunological Disease Modeling & Pharmacodynamics Services

Creative Biolabs offers a variety of well-established disease models to evaluate the efficacy of treatments for Inflammation & Immunological Diseases. These models simulate human disease conditions, enabling the assessment of potential therapies and advancing research in the field.

Introduction

Inflammation and immunological diseases encompass a wide range of disorders caused by abnormal immune system responses. These conditions can lead to chronic inflammation, tissue damage, and impaired organ function. Common examples include rheumatoid arthritis, lupus, inflammatory bowel disease (IBD), multiple sclerosis, and psoriasis. Inflammation plays a crucial role in the pathogenesis of these diseases, often involving dysregulated immune responses such as overactivation of immune cells or autoimmunity, where the immune system attacks the body's own tissues. The clinical manifestations can vary, from joint pain and skin lesions to systemic symptoms like fever and fatigue. The underlying mechanisms involve complex interactions between genetic, environmental, and immunological factors, which result in prolonged inflammation and immune dysfunction. Understanding these mechanisms is critical for developing effective treatments. Many immunological diseases are treated with immunosuppressive drugs, biologics, and targeted therapies aimed at modulating the immune response.

Inflammation & Immunological Disease Models

Our inflammation and immunological disease models are built using various methods, including chemical induction, genetic modification, and immune cell manipulation to simulate human-like immune responses. These models are characterized by their ability to replicate both the acute and chronic phases of disease, offering comprehensive platforms to study inflammation's progression and treatment responses.

Systemic Inflammation Models
Colitis Models Rheumatoid Arthritis (RA) Models
Experimental Autoimmune Encephalomyelitis (EAE) Models Systemic Lupus Erythematosus (SLE) Models Psoriasis Models
Peritonitis Models
  • Monosodium Urate (MSU) induced Peritonitis Model
  • Zymosan induced Peritonitis Model
Atopic Dermatitis & Eczema Models
  • Dinitrofluorobenzene (DNFB) induced Atopic Dermatitis Model
  • House Dust Mite (HDM) induced Atopic Dermatitis Model
  • Oxazolone (OXZ) induced Atopic Dermatitis Model
  • Ovalbumin (OVA) induced Atopic Dermatitis Model
  • Calcipotriol (MC903) induced Atopic Dermatitis Model
  • Fluorescein Isothiocyanate (FITC) induced Atopic Dermatitis Model
  • Ovalbumin (OVA) & Calcipotriol (MC903) induced Atopic Dermatitis Model
Sepsis Models Experimental Sjögren's Syndrome (ESS) Models
  • Submandibular Gland (SG) Protein induced Sjogren's Syndrome Mice Model
Gouty Arthritis (GA) Models
  • Monosodium Urate induced Air-pouch Model of Gouty Arthritis in Rats
  • Monosodium Urate induced Gouty Arthritis in Rats
GVHD Models
  • Acute GVHD Model
  • Chronic GVHD Model
Asthma Models Osteoarthritis Models Delayed Type Hypersensitivity (DTH) Rodent Models Passive Cutaneous Anaphylaxis (PCA) Models
  • Anti-DNP-IgE Antibody induced Urticaria Model
Experimental Autoimmune Neuritis (EAN) Models
  • P0180-199 Peptide induced Experimental Autoimmune Neuritis Rat Model
Ocular Inflammation Models
Experimental Autoimmune Myasthenia Gravis (EAMG) Models
  • Antigen induced EAMG Model
  • Transgenic Mice Spontaneous EAMG Model

Fig.1 Schematic of RA. (OA Literature) Fig. 1 The pathogenesis of RA.1,3

Evaluation Platform

  • Animals: Mouse, Rat, Hamster, Rabbit, Cat, Dog, NHPs.
  • Measurements
    We provide an extensive range of measurements for assessing drug efficacy in inflammation and immunological disease models, utilizing advanced technologies such as:
    • General Observations: Monitoring body weight, mortality, clinical signs of inflammation (e.g., redness, swelling), and behavioral changes (e.g., pain response).
    • Histopathology: Infiltration of immune cells (T-cells, macrophages) in target tissues using H&E and immunohistochemical staining.
    • Cytokine Profiling (ELISA): Quantification of key inflammatory cytokines like TNF-α, IL-6, IL-1β, and IFN-γ.
    • Hematology & Serum Analysis: Measurement of immune cell counts, liver enzymes, and markers of kidney function or inflammation.
    • Gene/Protein Expression Profiling: RT-PCR, Western blotting for inflammatory markers and immune cell activation pathways.

In addition to these standard methods, we tailor measurements to the specific requirements of your research project to provide comprehensive data and support every stage of your investigation.

Products

Inflammation & Immunological Disease Models Species Sample Type Catalog #
Adjuvant-Induced Arthritis (AIA) Models Lewis Rat Left ankle [FFPE block] ZAJJ-0524-JJ1
SD Rat Left ankle [FFPE block] ZAJJ-0524-JJ2
MIA-induced Osteoarthritis SD Rat Left knee joint [FFPE block] ZAJJ-0524-JJ3
OVX-Induced Osteoporosis SD Rat Serum Urine Femoral bone [FFPE block] ZAJJ-0524-JJ4
Carrageenan-Induced Paw Edema Model SD Rat Paw [FFPE block] ZAJJ-0524-JJ5
DSS-Induced Acute IBD Model Mouse Colon [FFPE block] Fecal ZAJJ-0524-JJ6
DSS-Induced Chronic IBD Model Mouse Colon [FFPE block] Fecal ZAJJ-0524-JJ7
TNBS-Induced Acute IBD Model SD Rat Colon [FFPE block] | Fecal ZAJJ-0524-JJ8

Applications

  • Testing anti-inflammatory drugs for chronic conditions like rheumatoid arthritis and psoriasis.
  • Assessing immune-modulating treatments for autoimmune diseases such as lupus and multiple sclerosis.
  • Evaluating antibiotics, antivirals, and anti-fungal agents in infection-related inflammation models.
  • Preclinical assessment of novel biologics and monoclonal antibodies for inflammation and immune-related diseases.
  • Research on inflammatory bowel disease (IBD) therapies, including Crohn's disease and ulcerative colitis.

Our advantages

  • Customized Solutions: We offer tailored models to suit the specific needs of your research, ensuring the highest relevance to your project.
  • Comprehensive Data Support: Our models provide detailed information, from histological analysis to cytokine profiling, helping you make informed decisions.
  • Expert Consultation: Our experienced scientific team supports model selection, experimental design, and data interpretation, ensuring high-quality results.
  • Cutting-Edge Technology: We use advanced techniques for biomarker detection and drug evaluation, providing robust, reproducible results.
  • Reliable Outcomes: Our disease models are validated and consistently generate reproducible results, enhancing the predictability of drug efficacy.

Work with Us

1
Inquiry Stage:
  • Summarize the project requirements and fill in the information collection form.
  • Sign a CDA from both parties to further communicate information, such as targets.
  • Select an animal model, discuss experimental design, and determine assay parameters.
  • Project costing and project schedule forecasting.
2
Project Start:
  • We provide a detailed project plan, including the required sample quantities, methods, and protocols.
  • Both parties confirm the project details and start the project.
  • Confirm the timeline of the project.
3
Project Progress:
  • We provide periodic results and information on the animal's condition.
  • We will work together to make project adjustments as necessary.
4
Project Completion:
  • We provide a comprehensive project report promptly.
  • We arrange transportation for the produced samples.
  • We provide a discussion of the project results and help to arrange the next steps.
5
After-Sales Support:
  • Data storage and archiving.

FAQs

  1. 1. What diseases can be modeled using your platforms?

    We offer models for a wide range of inflammation and immunological diseases, including autoimmune disorders, chronic inflammation, and infectious diseases.

  2. 2. Are the models customizable?

    Yes, we tailor our disease models to suit your specific research needs, from drug efficacy testing to immune response analysis.

  3. 3. How can I select the right model for my study?

    Our team of experts can help guide you in choosing the most suitable model based on your therapeutic target and research goals.

  4. 4. Do you provide data analysis services?

    Yes, our scientific team offers full support, including experimental design, data collection, and analysis, ensuring high-quality outcomes.

  5. 5. What types of measurements can be used to evaluate drug efficacy?

    We offer a broad range of assays, including histology, cytokine profiling, gene/protein expression analysis, and more, tailored to your project needs.

Published Data

Fig.2 Representative pictures of hind paws of control and CIA rats. (OA Literature)Fig. 2 Representative photographs of hind paws of control and CIA rats.2,3

Collagen induced arthritis (CIA) was induced in rats by immunization with type II collagen, as illustrated in Figure 2(A). The clinical signs of arthritis, characterized by mild periarticular erythema and edema, were first observed in the hind paws approximately 10 days post-immunization. The disease progressed in both frequency and severity over time, reaching a plateau in the peak CIA response between days 15 to 30, with a mean Arthritis Index (AI) of 125.01 [Figure 2(B)]. No significant enlargement of the hind paw diameter was observed over the course of the study. The severity of hind paw swelling and erythema progressively worsened, with maximum arthritis scores of approximately 8 recorded between days 12 and 30 in rats immunized with type II collagen [Figure 2(C)]. No macroscopic evidence of swelling or erythema was noted in the control rats.

Case Study

You can find the most appropriate model to evaluate the efficacy of your drug candidate.


For Research Use Only.


Online Inquiry
Name:
Phone:
*E-mail Address:
*Service & Products Interested:
Project Description: